Reports for PENDOPHARM DIVISION OF PHARMASCIENCE INC
Company Name
PENDOPHARM DIVISION OF PHARMASCIENCE INC
Totals |
||
Shortage reports |
129 |
|
| Actual shortage: | 2 (2%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 5 (4%) | |
| Resolved: | 122 (95%) | |
Discontinuation Reports |
3 |
|
| To be discontinued: | 0 (0%) | |
| Discontinued: | 2 (67%) | |
| Reversed: | 1 (33%) | |
Late reports |
17 (13%) |
|
Overdue reports |
0 (0%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| PDP-ERYTHROMYCIN | 5MG | OINTMENT | Actual shortage | 2025-07-23 | 2025-07-24 | 263358 |
| SOLYSTAT | 250MG | SUSPENSION | Resolved | 2025-05-06 | 2025-08-11 | 256751 |
| SOLYSTAT | 250MG | SUSPENSION | Resolved | 2025-03-10 | 2025-05-09 | 252253 |
| SOLYSTAT | 250MG | SUSPENSION | Resolved | 2025-02-26 | 2025-04-03 | 251258 |
| PDP-ISONIAZID | 50MG | SOLUTION | Resolved | 2025-01-30 | 2025-03-26 | 249056 |
| PDP-DESONIDE | 0.05% | CREAM | Resolved | 2024-12-03 | 2024-12-09 | 244645 |
| SOLYSTAT | 250MG | SUSPENSION | Resolved | 2024-12-03 | 2025-02-24 | 244642 |
| SOLYSTAT | 250MG | SUSPENSION | Resolved | 2024-10-30 | 2024-11-09 | 241585 |
| SOLYSTAT | 250MG | SUSPENSION | Resolved | 2024-10-30 | 2025-01-18 | 241582 |
| MYINFLA | 0.5MG | TABLET (EXTENDED-RELEASE) | Resolved | 2024-10-11 | 2025-05-08 | 239848 |
| AXID | 150MG | CAPSULE | Resolved | 2024-10-11 | 2024-11-23 | 239845 |
| SOLYSTAT | 1G | POWDER FOR SUSPENSION POWDER | Resolved | 2024-07-30 | 2024-10-16 | 234061 |
| SOLYSTAT | 250MG | SUSPENSION | Resolved | 2024-07-15 | 2024-08-31 | 232936 |
| PHENOBARB | 60MG | TABLET | Resolved | 2024-07-15 | 2024-07-27 | 232933 |
| PHENOBARB ELIXIR | 5MG | SOLUTION ELIXIR | Resolved | 2024-07-15 | 2024-12-11 | 232926 |
| XYLAC | 2.5MG | TABLET | Resolved | 2024-07-11 | 2024-09-23 | 232696 |
| PDP-ERYTHROMYCIN | 5MG | OINTMENT | Resolved | 2024-05-08 | 2024-10-28 | 227343 |
| XYLAC | 10MG | TABLET | Resolved | 2024-04-29 | 2024-11-14 | 226445 |
| XYLAC | 25MG | TABLET | Resolved | 2024-03-19 | 2024-11-14 | 222737 |
| XYLAC | 2.5MG | TABLET | Resolved | 2024-02-22 | 2024-05-10 | 220293 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| IBAVYR | 200MG | TABLET | Discontinued | 2023-01-20 | 2023-01-20 | 182060 |
| IBAVYR | 400MG | TABLET | Discontinued | 2023-01-20 | 2023-01-20 | 182029 |
| OCPHYL | 500MCG | SOLUTION | Reversed | 2017-04-10 | 2017-04-10 | 6237 |
Showing 1 to 3 of 3